Microscopically small, newly formed tumors may rest in dormant state for months or even years without forming their own blood vessels. It takes a kind of cellular switch to activate genes that are required for the sprouting of new blood vessels. New vessel formation is often accompanied by rapid, invasive tumor growth and metastasis. Drugs directed against key molecules of angiogenesis are already successfully used today to prolong survival of many cancer patients.
Dr. Dr. Amir Abdollahi and Professor Dr. Dr. Peter Huber at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), collaborating with Heidelberg University and US researchers, have investigated what happens at the molecular level when the angiogenetic switch is operated. The investigators studied the genetic response of blood vessel cells (endothelial cells) to known angiogenesis-promoting factors as well as angiogenesis inhibitors. In the “proangiogenetic” state, angiogenesis-promoting genes are switched on, while antiangiogenetic genes are switched off. The organism responds by sprouting new blood vessels. When the gene network is in “antiangiogenetic” state, the reverse is the case, i.e. the formation of blood vessels is prevented.
Measurements of gene activity in tissues samples of patients with diseases of the pancreas have shown the clinical relevance of these findings. From normal pancreatic tissue via chronic pancreatitis through to pancreatic cancer the researchers found a steady increase in the activity of those genes that had been identified in the cell experiment as angiogenesis-promoting. This trend was studied in more detail on a gene called PPARd, whose role in tumor development and angiogenesis had not been known before. The scientists were able to show that the level of PPARd protein steadily increases from normal tissue via pancreatitis tissue through to metastasizing pancreatic cancer. Other tumors, such as breast cancer and prostate cancer, were also found to produce increased levels of the angiogenesis-promoting protein.
In order to study the protein’s actual role in tumor vessel formation, the investigators transplanted skin and lung cancer cells into genetically engineered mice that do not produce their own PPARd. Compared to normal animals, tumor growth in the genetically engineered mice was signifantly slower with poorer supply of vessels.
However, PPARd is only one of many key switches within the angiogenetic network. “Regulation of angiogenesis seems to be more complex than previously assumed,“ says project leader Peter Huber. “Therefore we think that in cancer treatment it is not sufficient to inhibit only one of the participants. Antiangiogenetic therapy might be improved by targeting several of the network’s key switches. One of these could be PPARd.”
The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.).
Press Officer | alfa
Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)
CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Earth Sciences
19.01.2017 | Life Sciences
19.01.2017 | Physics and Astronomy